Brain-computer interface technology reaches a critical milestone in 2026 as human trials demonstrate practical applications for paralysis patients, enabling thought-driven communication and movement control, though safety and ethical challenges remain.

Medical AI startup OpenEvidence, known as the 'ChatGPT for doctors,' has doubled its valuation to $12 billion after a new $250 million funding round. The platform is now used by over 40% of US physicians.